CoreCap Advisors’s Replimune Group REPL Stock Holding History

CoreCap Advisors’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.75K	Sell	208 -30	-13%	-$379	﹤0.01%	2410
2026 Q2	$2.64K	Buy	238 +236	+11,800%	+$1.44K	﹤0.01%	2468
2026 Q1	$15	Hold	2	–	–	﹤0.01%	2912
2025 Q4	$19	Hold	2	–	–	﹤0.01%	2929
2025 Q3	$8	Buy	+2	New	+$13	﹤0.01%	2778

Other funds holding REPL

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors's REPL Position: Q3 2026 in Review

CoreCap Advisors reduced its Replimune Group (REPL) stake by 13% in Q3 2026, selling an estimated $379 and leaving 208 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

CoreCap Advisors first reported a position in REPL in Q3 2025 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

CoreCap Advisors held 208 shares of Replimune Group worth $2.75K as of Q3 2026.
CoreCap Advisors sold 30 Replimune Group shares in Q3 2026, an estimated $379.
Replimune Group made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2410 holding.
CoreCap Advisors first reported a position in Replimune Group in Q3 2025 and has held it in 5 quarters since.
13 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.